November 18, 2014 - The Heart Rhythm Society convened a research symposium on December 9–10, 2013, in Washington, DC, that focused on the prevention of atrial fibrillation (AF) as well as AF-related stroke and morbidity.Attendees sought to summarize advances in understanding AF since a 2008 National Institutes of Health(NIH) conference on this topic and to identify continued knowledge gaps and current research priorities. This resultant whitepaper was developed in collaboration with and endorsed by the European Heart Rhythm Association (EHRA) and the Canadian Heart Rhythm Society (CHRS). It summarizes the deliberations of the attendees in an effort to accelerate progress toward preventing AF and its consequences.
Clinical Guidelines & Documents
Authored and endorsed clinical documents provide three main components vital to advancements in the heart rhythm field: analysis, discussion of current issues, and suggestions for clinical application. Below are the documents HRS is currently working on (scheduled for publication in 2015):
HRS/EHRA/APHRS/SOLAECE Expert Consensus Statement on ICD Programming and Testing
Scope: The consensus statement will focus on optimal programming for primary and secondary prevention ICDs, inappropriate shock avoidance programming (detection times, SVT discrimination, ATP), and use of defibrillation testing.
HRS Expert Consensus Statement on Diagnosis and Treatment of Postural Tachycardia Syndrome (POTS), Inappropriate Sinus Tachycardia (IST) and Vasovagal Syncope (VVS)
Scope: The consensus statement will focus on the diagnosis and management of autonomic dysfunction syndromes.
HRS Expert Consensus Statement on Remote Monitoring
Scope: The consensus statement will focus on providing a review of different modalities, indications, utility, implementation and remote monitoring of Cardiovascular Implantable Electronic Devices.
Please email firstname.lastname@example.org should you have questions or need further information.
Featured Clinical Documents
August 25, 2014 - This document on the Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary or valve interventions is a joint consensus document of the European Society of Cardiology Working Group on Thrombosis, European Heart Rhythm Association (EHRA), European Association of Percutaneous Cardiovascular Interventions (EAPCI) and European Association of Acute Cardiac Care (ACCA) endorsed by the Heart Rhythm Society (HRS) and Asia-Pacific Heart Rhythm Society (APHRS).
May 9, 2014 - This international expert consensus statement was written by experts in the field who were chosen by the Heart Rhythm Society in collaboration with representatives from the American College of Cardiology, American College of Chest Physicians, American Heart Association, Asia Pacific Heart Rhythm Society, European Hear Rhythm Association, and World Association for Sarcoidosis and Other Granulomatous Disorders (WASOG).
May 8, 2014 - This expert consensus statement was developed in partnership between the Pediatric and Congenital Electrophysiology Society (PACES) and the Heart Rhythm Society (HRS) and endorsed by the governing bodies of PACES, HRS, the American College of Cardiology (ACC), the American Heart Association (AHA), the European Heart Rhythm Association (EHRA), the Canadian Heart Rhythm Society (CHRS), and the International Society for Adult Congenital Heart Disease (ISACHD).